Our Team

TILT’s founder and CEO, Akseli Hemminki is a biotech entrepreneur and cancer clinician who has personally treated almost 300 patients with ten different oncolytic viruses. Akseli leads a team of experienced industry professionals who collectively have decades of experience in the research, development, and commercialization of cancer therapeutics

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer, Chair of the Board of Directors

Juha Pihlman

BSc, CFO consultant

Suvi Sorsa

PhD, VP of Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP of Business Development

John Goldfinch

MBA, CRM, US Clinical Lead

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

Riikka Havunen

PhD, Head of R&D

João Manuel Santos

PhD, Head of Immunology

Cristina Pereira

PhD, Head of Manufacturing

Veera Kukkurainen

MSc, Head of Operations

Henrik Roosvall

Business Operations Manager

James Clubb

MSc, Project Manager

Dafne Quixabeira

MSc, Project Manager

Remi Gloeckler

PhD, CMC Advisor